These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7060002)

  • 1. Depletion of lymphocyte subpopulations in primary and secondary lymphoid organs of mice by a transplanted granulocytosis-inducing mammary carcinoma.
    Lee MY; Rosse C
    Cancer Res; 1982 Apr; 42(4):1255-60. PubMed ID: 7060002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A granulocytosis-inducing tumor inhibits the production of B lymphocytes in murine bone marrow.
    Fülöp G; Lee MY; Rosse C
    J Immunol; 1985 Dec; 135(6):4266-72. PubMed ID: 3877765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors.
    DuPre' SA; Hunter KW
    Exp Mol Pathol; 2007 Feb; 82(1):12-24. PubMed ID: 16919266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of fatty marrow by active granulocytopoietic bone marrow following transplantation of mammary carcinoma into mice.
    Lee MY; Rosse C
    Anat Rec; 1979 Sep; 195(1):31-46. PubMed ID: 496027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic switch from lymphoid to granulocytic development in 3LL tumor-bearing mice.
    Lee JK; Back TC; Komschlies KL; Ruscetti FW; Young HA; Wiltrout RH
    In Vivo; 2001; 15(4):255-63. PubMed ID: 11695215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemopoietic effects in mice of a transplanted, granulocytosis-inducing tumor.
    Reincke U; Burlington H; Carsten AL; Cronkite EP; Laissue JA
    Exp Hematol; 1978 Apr; 6(4):421-30. PubMed ID: 306350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of murine natural killer cells by a granulocytosis-inducing tumor.
    Pollack SB; Lee MY; Cohen E; Lottsfeldt JL; Rosse C
    Cancer Res; 1989 Jan; 49(1):174-8. PubMed ID: 2908844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent activation of granulocytes and osteoclasts in busulfan-suppressed bone marrow in response to transplantation of a mammary carcinoma in mice.
    McCracken CH; Lottsfeldt JL; Lee MY
    Exp Hematol; 1988 May; 16(4):285-9. PubMed ID: 3360066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of granulocytic hyperplasia, thymic atrophy, and hypercalcemia by a selected subpopulation of a murine mammary adenocarcinoma.
    Thomas E; Smith DC; Lee MY; Rosse C
    Cancer Res; 1985 Nov; 45(11 Pt 2):5840-4. PubMed ID: 4053054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations and function in chronic murine toxoplasmosis.
    Macario AJ; Stahl W; Miller R
    Clin Exp Immunol; 1980 Sep; 41(3):415-22. PubMed ID: 6969157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinetic study on the deletion of thymic, peripheral, and gut-associated V beta 6+ T cells in an Mls-1b BALB/c colony infected with an exogenous mouse mammary tumor virus.
    Tucek CL; Desaymard C; Papiernik M
    J Immunol; 1993 Jul; 151(2):759-66. PubMed ID: 8101538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of stress in normal and adrenalectomized mice.
    Rocha B
    Eur J Immunol; 1985 Nov; 15(11):1131-5. PubMed ID: 4065199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological aspects of rat mammary cancer therapy with soluble tumor-associated antigens and anticancer drugs.
    Zusman I
    Med Sci Monit; 2005 May; 11(5):RA173-181. PubMed ID: 15874908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCID mouse as a model for transplantation studies.
    Renz JF; Lin Z; de Roos M; Dalal AA; Ascher NL
    J Surg Res; 1996 Sep; 65(1):34-41. PubMed ID: 8895604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Apr; 289():1-277. PubMed ID: 12748714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs.
    Santer V; Mastromarino JH; Lala PK
    Int J Cancer; 1980 Jan; 25(1):159-68. PubMed ID: 6967460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.